BBS-Bioactive Bone Substitutes Oyj (BONEH.HE)

EUR 0.06

(-4.3%)

Annual Income Statements

(In EUR)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - 105.68 Thousand -
Cost of Revenue 3619.00 29.95 Thousand 56.94 Thousand 83.06 Thousand 105.68 Thousand 128.25 Thousand
Gross Profit -3619.00 -29.95 Thousand -56.94 Thousand -83.06 Thousand - -128.25 Thousand
Operating Expenses 3.36 Million 2.92 Million 2.51 Million 2.56 Million 1.43 Million -605.73 Thousand
Selling, General and Administrative Expenses 1.24 Million 2.79 Million 2.4 Million 2.47 Million 1.36 Million 872.12 Thousand
Research and Development Expenses - - - - - -
Other Expenses 2.11 Million 2.92 Million 2.51 Million 2.56 Million 1.43 Million -605.73 Thousand
Cost and Expenses 3.36 Million 2.95 Million 2.57 Million 2.64 Million 1.53 Million -477.47 Thousand
Operating Income -3.36 Million -2.95 Million -2.57 Million -2.64 Million -1.53 Million 477.47 Thousand
Interest Expense 116.97 Thousand 141.05 Thousand 199.88 Thousand 85.91 Thousand 102.21 Thousand 97.63 Thousand
Income Tax Expense 3.00 141.01 Thousand 200.21 Thousand 85.91 Thousand 102.62 Thousand 1.80
Earnings before Tax -3.48 Million -3.09 Million -2.77 Million -2.73 Million -1.63 Million 379.83 Thousand
Net Income -3.48 Million -3.23 Million -2.97 Million -2.81 Million -1.74 Million 379.83 Thousand
Earnings Per Share Basic -0.29 -0.33 -0.35 -0.37 -0.24 0.06
Earnings Per Share Diluted -0.29 -0.33 -0.35 -0.37 -0.24 0.06
Weighted Average Shares Outstanding 12.09 Million 9.82 Million 8.45 Million 7.55 Million 7.28 Million 6.02 Million
Weighted Average Shares Outstanding (Diluted) 12.09 Million 9.82 Million 8.45 Million 7.55 Million 7.28 Million 6.02 Million
Gross Margin - - - - - -
EBIT Margin - - - - -12.40 -
Profit Margin - - - - -16.47 -
EBITDA -3.14 Million -2.72 Million -2.33 Million -2.43 Million -1.31 Million 632.47 Thousand
Earnings Before Tax Margin - - - - -14.53 -

Income Statement Charts